{
  "SNES": {
    "ticker": "SNES",
    "news": [],
    "hod": false,
    "float": "1.00M",
    "price": "4.21",
    "time": "01:58:03",
    "isActive": true,
    "firstSeen": "2024-12-16T08:37:51.982Z",
    "lastSeen": "2024-12-16T08:37:51.983Z",
    "filings": [
      {
        "formType": "S-3",
        "description": "Registration statement under Securities Act of 1933\nAcc-no: 0001213900-24-081019 (33 Act)  Size: 411 KB",
        "date": "2024-09-23"
      }
    ],
    "shorts": {
      "Settlement Date": "Nov 29, 2024",
      "Short Interest": 46440,
      "Avg. Daily Volume": 980000,
      "Short Float": 51680,
      "Short Ratio": "4.74%"
    }
  },
  "SIDU": {
    "ticker": "SIDU",
    "news": [],
    "hod": false,
    "float": "8.37M",
    "price": "5.1",
    "time": "10:00:48",
    "isActive": true,
    "firstSeen": "2024-12-16T09:00:48.192Z",
    "lastSeen": "2024-12-16T22:01:36.518Z",
    "shorts": {
      "Settlement Date": "Nov 29, 2024",
      "Short Interest": 303450,
      "Avg. Daily Volume": 8369999.999999999,
      "Short Float": 494840,
      "Short Ratio": "3.63%"
    }
  },
  "AMPG": {
    "ticker": "AMPG",
    "news": [],
    "hod": false,
    "float": "9.54M",
    "price": "2.75",
    "time": "10:10:56",
    "isActive": true,
    "firstSeen": "2024-12-16T09:10:55.398Z",
    "lastSeen": "2024-12-16T22:10:47.918Z",
    "filings": [
      {
        "formType": "S-3/A",
        "description": "[Amend] Registration statement under Securities Act of 1933\nAcc-no: 0001493152-24-015341 (33 Act)  Size: 61 KB",
        "date": "2024-04-19"
      }
    ],
    "shorts": {
      "Settlement Date": "Nov 29, 2024",
      "Short Interest": 114350,
      "Avg. Daily Volume": 9160000,
      "Short Float": 98330,
      "Short Ratio": "1.25%"
    }
  },
  "PRZO": {
    "ticker": "PRZO",
    "news": [
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-12-16T10:09:39Z",
        "headline": "ParaZero Technologies Regains Nasdaq Compliance, Maintains Stock Listing",
        "id": 42503240,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "PRZO"
        ],
        "updated_at": "2024-12-16T10:09:39Z",
        "url": "https://www.benzinga.com/government/24/12/42503240/parazero-technologies-regains-nasdaq-compliance-maintains-stock-listing",
        "added_at": "2024-12-16T10:14:20.159Z"
      }
    ],
    "hod": false,
    "float": "9.01M",
    "price": "1.65",
    "time": "11:03:47",
    "isActive": true,
    "firstSeen": "2024-12-16T10:04:12.979Z",
    "lastSeen": "2024-12-16T10:06:51.793Z",
    "shorts": {
      "Settlement Date": "Nov 29, 2024",
      "Short Interest": 701500,
      "Avg. Daily Volume": 9010000,
      "Short Float": 3680000,
      "Short Ratio": "7.79%"
    }
  },
  "BTCT": {
    "ticker": "BTCT",
    "news": [],
    "hod": false,
    "float": "4.25M",
    "price": "7.29",
    "time": "12:10:18",
    "isActive": true,
    "firstSeen": "2024-12-16T11:10:29.342Z",
    "lastSeen": "2024-12-16T13:19:19.023Z",
    "shorts": {
      "Settlement Date": "Nov 29, 2024",
      "Short Interest": 326110,
      "Avg. Daily Volume": 3130000,
      "Short Float": 3590000,
      "Short Ratio": "10.42%"
    }
  },
  "RCAT": {
    "ticker": "RCAT",
    "news": [
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-12-16T21:13:42Z",
        "headline": "CORRECTION: Red Cat Holdings Q2 EPS $(0.18) Misses $(0.08) Estimate, Sales $1.53M Miss $4.13M Estimate",
        "id": 42517887,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "RCAT"
        ],
        "updated_at": "2024-12-16T21:13:42Z",
        "url": "https://www.benzinga.com/news/earnings/24/12/42517887/correction-red-cat-holdings-q2-eps-0-18-misses-0-08-estimate-sales-1-53m-miss-4-13m-estimate",
        "added_at": "2024-12-16T21:14:31.829Z"
      },
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-12-16T21:18:56Z",
        "headline": "Red Cat Sees FY25 Revenue $80M-$120M",
        "id": 42518137,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "RCAT"
        ],
        "updated_at": "2024-12-16T21:18:57Z",
        "url": "https://www.benzinga.com/news/24/12/42518137/red-cat-sees-fy25-revenue-80m-120m",
        "added_at": "2024-12-16T21:19:31.838Z"
      }
    ],
    "isActive": true,
    "filings": [
      {
        "formType": "S-3/A",
        "description": "[Amend] Registration statement under Securities Act of 1933\nAcc-no: 0001554795-24-000331 (33 Act)  Size: 309 KB",
        "date": "2024-12-05"
      },
      {
        "formType": "S-3",
        "description": "Registration statement under Securities Act of 1933\nAcc-no: 0001554795-24-000288 (33 Act)  Size: 302 KB",
        "date": "2024-11-14"
      }
    ],
    "shorts": {
      "Settlement Date": "Nov 29, 2024",
      "Short Interest": 6880000,
      "Avg. Daily Volume": 57090000,
      "Short Float": 3120000,
      "Short Ratio": "12.05%"
    }
  },
  "LRMR": {
    "ticker": "LRMR",
    "news": [
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-12-16T12:02:16Z",
        "headline": "Larimar Therapeutics Reports Data From Rare Disease Drug Study",
        "id": 42504934,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "LRMR"
        ],
        "updated_at": "2024-12-16T12:02:16Z",
        "url": "https://www.benzinga.com/news/24/12/42504934/larimar-therapeutics-reports-data-from-rare-disease-drug-study",
        "added_at": "2024-12-16T12:26:39.397Z"
      },
      {
        "author": "Vandana Singh",
        "content": "",
        "created_at": "2024-12-16T17:17:50Z",
        "headline": "Why Is Larimar Therapeutics Stock Trading Lower On Monday?",
        "id": 42513317,
        "images": [
          {
            "size": "large",
            "url": "https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/12/16/LRMR.png"
          },
          {
            "size": "small",
            "url": "https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/12/16/LRMR.png"
          },
          {
            "size": "thumb",
            "url": "https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/12/16/LRMR.png"
          }
        ],
        "source": "benzinga",
        "summary": "Larimar Therapeutics shares long-term OLE study data on nomlabofusp, showing increased FXN levels in Friedreich&#39;s Ataxia patients and well-tolerated treatment.",
        "symbols": [
          "LRMR"
        ],
        "updated_at": "2024-12-16T17:17:51Z",
        "url": "https://www.benzinga.com/general/biotech/24/12/42513317/why-is-larimar-therapeutics-stock-trading-lower-on-monday",
        "added_at": "2024-12-16T21:04:40.754Z"
      },
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-12-16T17:01:37Z",
        "headline": "HC Wainwright & Co. Reiterates Buy on Larimar Therapeutics, Maintains $15 Price Target",
        "id": 42512885,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "LRMR"
        ],
        "updated_at": "2024-12-16T17:01:38Z",
        "url": "https://www.benzinga.com/news/24/12/42512885/hc-wainwright-co-reiterates-buy-on-larimar-therapeutics-maintains-15-price-target",
        "added_at": "2024-12-16T21:04:40.775Z"
      },
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-12-16T15:06:09Z",
        "headline": "Larimar Therapeutics Shares Resumed Trade",
        "id": 42510050,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "LRMR"
        ],
        "updated_at": "2024-12-16T15:06:10Z",
        "url": "https://www.benzinga.com/trading-ideas/24/12/42510050/larimar-therapeutics-shares-resumed-trade",
        "added_at": "2024-12-16T21:04:40.784Z"
      }
    ],
    "isActive": true,
    "filings": [
      {
        "formType": "S-3",
        "description": "Registration statement under Securities Act of 1933\nAcc-no: 0001193125-24-135337 (33 Act)  Size: 2 MB",
        "date": "2024-05-09"
      }
    ],
    "shorts": {
      "Settlement Date": "Nov 29, 2024",
      "Short Interest": 3880000,
      "Avg. Daily Volume": 37010000,
      "Short Float": 741030,
      "Short Ratio": "10.48%"
    }
  },
  "CETX": {
    "ticker": "CETX",
    "news": [
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-12-16T12:32:13Z",
        "headline": "Cemtrex Says Vicon Industries Subsidiary Received $10.4M Order For A State Government Corrections Facility In The Mid-Atlantic Region",
        "id": 42505618,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "CETX"
        ],
        "updated_at": "2024-12-16T12:32:13Z",
        "url": "https://www.benzinga.com/news/24/12/42505618/cemtrex-says-vicon-industries-subsidiary-received-10-4m-order-for-a-state-government-corrections-fac",
        "added_at": "2024-12-16T12:34:34.514Z"
      }
    ],
    "hod": false,
    "float": "1.34M",
    "price": "4.54",
    "time": "13:31:14",
    "isActive": true,
    "firstSeen": "2024-12-16T12:31:22.455Z",
    "lastSeen": "2024-12-16T13:04:41.529Z",
    "shorts": {
      "Settlement Date": "Nov 29, 2024",
      "Short Interest": 176550,
      "Avg. Daily Volume": 730000,
      "Short Float": 208420,
      "Short Ratio": "24.19%"
    }
  },
  "ONDS": {
    "ticker": "ONDS",
    "news": [],
    "isActive": true,
    "shorts": {
      "Settlement Date": "Nov 29, 2024",
      "Short Interest": 1890000,
      "Avg. Daily Volume": 69380000,
      "Short Float": 669000,
      "Short Ratio": "2.72%"
    }
  },
  "AEHR": {
    "ticker": "AEHR",
    "news": [
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-12-16T12:37:32Z",
        "headline": "Aehr Test Systems Secures $10M Order for AI Semiconductor Testing",
        "id": 42505803,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "AEHR"
        ],
        "updated_at": "2024-12-16T12:37:33Z",
        "url": "https://www.benzinga.com/news/24/12/42505803/aehr-test-systems-secures-10m-order-for-ai-semiconductor-testing",
        "added_at": "2024-12-16T12:59:02.158Z"
      },
      {
        "author": "Dylan Berman",
        "content": "",
        "created_at": "2024-12-16T16:29:34Z",
        "headline": "What's Going On With Aehr Test Systems Shares Monday?",
        "id": 42512037,
        "images": [
          {
            "size": "large",
            "url": "https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/12/16/business-5475664-1280.jpeg"
          },
          {
            "size": "small",
            "url": "https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/12/16/business-5475664-1280.jpeg"
          },
          {
            "size": "thumb",
            "url": "https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/12/16/business-5475664-1280.jpeg"
          }
        ],
        "source": "benzinga",
        "summary": "Aehr stock is trading higher on Monday after the company announced that it secured a $10 million order for artificial intelligence semiconductor testing.",
        "symbols": [
          "AEHR"
        ],
        "updated_at": "2024-12-16T16:29:35Z",
        "url": "https://www.benzinga.com/trading-ideas/movers/24/12/42512037/whats-going-on-with-aehr-test-systems-shares-monday",
        "added_at": "2024-12-16T21:04:39.818Z"
      }
    ],
    "isActive": true,
    "filings": [
      {
        "formType": "S-3",
        "description": "Registration statement under Securities Act of 1933\nAcc-no: 0001654954-24-012994 (33 Act)  Size: 1 MB",
        "date": "2024-10-15"
      }
    ],
    "shorts": {
      "Settlement Date": "Nov 29, 2024",
      "Short Interest": 6380000,
      "Avg. Daily Volume": 27670000,
      "Short Float": 1170000,
      "Short Ratio": "23.05%"
    }
  },
  "RVPH": {
    "ticker": "RVPH",
    "news": [
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-12-16T13:06:52Z",
        "headline": "Reviva Announces Preliminary Topline Data For Long-Term Open Label Extension Portion Of Phase 3 RECOVER Study Of Brilaroxazine In Schizophrenia; Says Once Daily Brilaroxazine Demonstrated Favorable Long-Term Safety And Robust Broad-Spectrum Efficacy Sustained Over One Year",
        "id": 42506617,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "RVPH"
        ],
        "updated_at": "2024-12-16T13:06:53Z",
        "url": "https://www.benzinga.com/general/biotech/24/12/42506617/reviva-announces-preliminary-topline-data-for-long-term-open-label-extension-portion-of-phase-3-r",
        "added_at": "2024-12-16T13:12:03.465Z"
      },
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-12-16T22:22:10Z",
        "headline": "Reviva  Proposes To Offer And Sell Shares Of Its Common Stock And Warrants In Public Offering; No Terms Disclosed",
        "id": 42520001,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "RVPH"
        ],
        "updated_at": "2024-12-16T22:22:11Z",
        "url": "https://www.benzinga.com/news/24/12/42520001/reviva-proposes-to-offer-and-sell-shares-of-its-common-stock-and-warrants-in-public-offering-no-term",
        "added_at": "2024-12-16T22:24:32.445Z"
      }
    ],
    "isActive": true,
    "shorts": {
      "Settlement Date": "Nov 29, 2024",
      "Short Interest": 6160000,
      "Avg. Daily Volume": 28500000,
      "Short Float": 463290,
      "Short Ratio": "21.62%"
    }
  },
  "EP": {
    "ticker": "EP",
    "news": [],
    "isActive": true,
    "shorts": {
      "Settlement Date": "Nov 29, 2024",
      "Short Interest": 1360000,
      "Avg. Daily Volume": 25060000,
      "Short Float": 33000,
      "Short Ratio": "5.41%"
    }
  },
  "NMHI": {
    "ticker": "NMHI",
    "news": [
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-12-16T13:33:03Z",
        "headline": "Nature's Miracle Holding To Acquire Controlling Stake In J&Y Marigold, Bolstering Bitcoin Mining Capabilities; To Purchase 90% Share For $5.32M",
        "id": 42507363,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "NMHI"
        ],
        "updated_at": "2024-12-16T13:33:04Z",
        "url": "https://www.benzinga.com/m-a/24/12/42507363/natures-miracle-holding-to-acquire-controlling-stake-in-j-y-marigold-bolstering-bitcoin-mining-capab",
        "added_at": "2024-12-16T13:34:25.162Z"
      }
    ],
    "hod": false,
    "float": "798.78K",
    "price": "2.94",
    "time": "14:31:11",
    "isActive": true,
    "firstSeen": "2024-12-16T13:31:47.706Z",
    "lastSeen": "2024-12-16T14:37:11.790Z",
    "shorts": {
      "Settlement Date": "Nov 29, 2024",
      "Short Interest": 102110,
      "Avg. Daily Volume": 520000,
      "Short Float": 1320000,
      "Short Ratio": "19.64%"
    }
  },
  "VSEE": {
    "ticker": "VSEE",
    "news": [
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-12-16T13:04:49Z",
        "headline": "VSee Health Announced A Partnership With Tele911; Terms Not Disclosed",
        "id": 42506475,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "VSEE"
        ],
        "updated_at": "2024-12-16T13:04:50Z",
        "url": "https://www.benzinga.com/news/24/12/42506475/vsee-health-announced-a-partnership-with-tele911-terms-not-disclosed",
        "added_at": "2024-12-16T13:39:43.400Z"
      }
    ],
    "hod": false,
    "float": "6.26M",
    "price": "1.6",
    "time": "14:39:36",
    "isActive": true,
    "firstSeen": "2024-12-16T13:39:41.063Z",
    "lastSeen": "2024-12-16T13:39:41.063Z",
    "shorts": {
      "Settlement Date": "Nov 29, 2024",
      "Short Interest": 349300,
      "Avg. Daily Volume": 6070000,
      "Short Float": 1850000,
      "Short Ratio": "5.75%"
    }
  },
  "CDIO": {
    "ticker": "CDIO",
    "news": [
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-12-16T13:35:56Z",
        "headline": "Cardio Diagnostics Holdings Receives Final Medicare Pricing Determination From Centers For Medicare And Medicaid Services",
        "id": 42507489,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "CDIO"
        ],
        "updated_at": "2024-12-16T13:35:57Z",
        "url": "https://www.benzinga.com/general/biotech/24/12/42507489/cardio-diagnostics-holdings-receives-final-medicare-pricing-determination-from-centers-for-medica",
        "added_at": "2024-12-16T13:48:27.811Z"
      }
    ],
    "isActive": true,
    "shorts": {
      "Settlement Date": "Nov 29, 2024",
      "Short Interest": 1550000,
      "Avg. Daily Volume": 34300000,
      "Short Float": 3030000,
      "Short Ratio": "4.53%"
    }
  },
  "IMMR": {
    "ticker": "IMMR",
    "news": [
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-12-16T14:14:38Z",
        "headline": "Immersion Q2 Adj EPS $1.22 Up From $0.26 YoY, Sales $616.25M Up From $6.98M YoY",
        "id": 42508578,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "IMMR"
        ],
        "updated_at": "2024-12-16T14:14:39Z",
        "url": "https://www.benzinga.com/news/earnings/24/12/42508578/immersion-q2-adj-eps-1-22-up-from-0-26-yoy-sales-616-25m-up-from-6-98m-yoy",
        "added_at": "2024-12-16T14:28:00.580Z"
      }
    ],
    "isActive": true,
    "shorts": {
      "Settlement Date": "Nov 29, 2024",
      "Short Interest": 3140000,
      "Avg. Daily Volume": 28720000,
      "Short Float": 671700,
      "Short Ratio": "10.95%"
    }
  },
  "CKPT": {
    "ticker": "CKPT",
    "news": [
      {
        "author": "Vandana Singh",
        "content": "",
        "created_at": "2024-12-16T14:22:01Z",
        "headline": "FDA Approves Checkpoint Therapeutics' Skin Cancer Drug One Year After Rejection",
        "id": 42508781,
        "images": [
          {
            "size": "large",
            "url": "https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/12/16/cancer.jpeg"
          },
          {
            "size": "small",
            "url": "https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/12/16/cancer.jpeg"
          },
          {
            "size": "thumb",
            "url": "https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/12/16/cancer.jpeg"
          }
        ],
        "source": "benzinga",
        "summary": "Checkpoint Therapeutics&#39; Unloxcyt wins FDA approval for advanced cSCC, marking the company&#39;s entry into the U.S. market, valued over $1 billion annually.",
        "symbols": [
          "CKPT"
        ],
        "updated_at": "2024-12-16T14:22:02Z",
        "url": "https://www.benzinga.com/general/biotech/24/12/42508781/fda-approves-checkpoint-therapeutics-skin-cancer-drug-one-year-after-rejection",
        "added_at": "2024-12-16T14:28:09.795Z"
      },
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-12-16T12:27:19Z",
        "headline": "HC Wainwright & Co. Reiterates Buy on Checkpoint Therapeutics, Maintains $20 Price Target",
        "id": 42505462,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "CKPT"
        ],
        "updated_at": "2024-12-16T12:27:20Z",
        "url": "https://www.benzinga.com/news/24/12/42505462/hc-wainwright-co-reiterates-buy-on-checkpoint-therapeutics-maintains-20-price-target",
        "added_at": "2024-12-16T14:28:09.795Z"
      },
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-12-16T07:35:33Z",
        "headline": "Reported Friday, FDA Approves Checkpoint Therapeutics' UNLOXCYT (cosibelimab-ipdl) For Advanced cSCC Treatment",
        "id": 42501882,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "CKPT"
        ],
        "updated_at": "2024-12-16T07:35:34Z",
        "url": "https://www.benzinga.com/news/24/12/42501882/reported-friday-fda-approves-checkpoint-therapeutics-unloxcyt-cosibelimab-ipdl-for-advanced-cscc-tre",
        "added_at": "2024-12-16T14:28:09.796Z"
      },
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-12-16T16:30:05Z",
        "headline": "Lake Street Maintains Buy on Checkpoint Therapeutics, Raises Price Target to $7",
        "id": 42512072,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "CKPT"
        ],
        "updated_at": "2024-12-16T16:30:05Z",
        "url": "https://www.benzinga.com/news/24/12/42512072/lake-street-maintains-buy-on-checkpoint-therapeutics-raises-price-target-to-7",
        "added_at": "2024-12-16T21:04:40.632Z"
      },
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-12-16T15:11:41Z",
        "headline": "Checkpoint Therapeutics shares are trading higher after the company announced that the FDA approved UNLOXCYT for the treatment of advanced cutaneous squamous cell carcinoma.",
        "id": 42510278,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "CKPT"
        ],
        "updated_at": "2024-12-16T15:11:42Z",
        "url": "https://www.benzinga.com/news/24/12/42510278/checkpoint-therapeutics-shares-are-trading-higher-after-the-company-announced-that-the-fda-approved",
        "added_at": "2024-12-16T21:04:40.647Z"
      }
    ],
    "isActive": true,
    "filings": [
      {
        "formType": "S-3",
        "description": "Registration statement under Securities Act of 1933\nAcc-no: 0001104659-24-090904 (33 Act)  Size: 295 KB",
        "date": "2024-08-19"
      },
      {
        "formType": "S-3",
        "description": "Registration statement under Securities Act of 1933\nAcc-no: 0001104659-24-041209 (33 Act)  Size: 241 KB",
        "date": "2024-03-29"
      }
    ],
    "shorts": {
      "Settlement Date": "Nov 29, 2024",
      "Short Interest": 6570000,
      "Avg. Daily Volume": 40570000,
      "Short Float": 756740,
      "Short Ratio": "16.20%"
    }
  },
  "GRRR": {
    "ticker": "GRRR",
    "news": [
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-12-16T19:01:52Z",
        "headline": "Gorilla Technology Group Shares Milestone Updates; Set To Enter 2025 With $93M Backlog; Expects Revenue $90M-$100M",
        "id": 42515298,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "GRRR"
        ],
        "updated_at": "2024-12-16T19:01:52Z",
        "url": "https://www.benzinga.com/news/24/12/42515298/gorilla-technology-group-shares-milestone-updates-set-to-enter-2025-with-93m-backlog-expects-revenue",
        "added_at": "2024-12-16T21:04:40.796Z"
      }
    ],
    "hod": true,
    "float": "9.49M",
    "price": "10.17",
    "time": "15:43:21",
    "isActive": true,
    "firstSeen": "2024-12-16T14:43:28.907Z",
    "lastSeen": "2024-12-16T14:52:11.409Z",
    "shorts": {
      "Settlement Date": "Nov 29, 2024",
      "Short Interest": 860420,
      "Avg. Daily Volume": 9440000,
      "Short Float": 829590,
      "Short Ratio": "9.11%"
    }
  },
  "WKEY": {
    "ticker": "WKEY",
    "news": [
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-12-16T14:53:03Z",
        "headline": "WISeKey International Holding Shares Resumed Trade",
        "id": 42509626,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "WKEY"
        ],
        "updated_at": "2024-12-16T14:53:04Z",
        "url": "https://www.benzinga.com/trading-ideas/24/12/42509626/wisekey-international-holding-shares-resumed-trade",
        "added_at": "2024-12-16T21:04:40.922Z"
      }
    ],
    "hod": false,
    "float": "3.20M",
    "price": "12.8",
    "time": "16:06:07",
    "isActive": true,
    "firstSeen": "2024-12-16T15:06:53.818Z",
    "lastSeen": "2024-12-16T21:53:44.046Z"
  },
  "OPTX": {
    "ticker": "OPTX",
    "news": [],
    "hod": true,
    "float": "6.06M",
    "price": "2.75",
    "time": "22:06:10",
    "isActive": true,
    "firstSeen": "2024-12-16T21:06:26.456Z",
    "lastSeen": "2024-12-16T22:29:44.620Z"
  },
  "XWEL": {
    "ticker": "XWEL",
    "news": [],
    "hod": true,
    "float": "4.24M",
    "price": "2.07",
    "time": "22:14:07",
    "isActive": true,
    "firstSeen": "2024-12-16T21:14:18.699Z",
    "lastSeen": "2024-12-16T22:11:57.088Z"
  }
}